Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Electromed, Inc. stock logo
ELMD
Electromed
$27.25
+2.3%		$38.25
$23.01
▼
$47.40
$227.97M0.4677,381 shs96,787 shs
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$0.72
-0.9%		$0.96
$0.67
▼
$4.71
$56.88M1.261.40 million shs833,121 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$62.81
+5.0%		$62.42
$23.47
▼
$77.00
$201.18M0.0661,145 shs63,035 shs
Profound Medical stock logo
PROF
Profound Medical
$5.97
+0.2%		$7.05
$3.90
▼
$8.95
$218.10M0.72105,980 shs362,006 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Electromed, Inc. stock logo
ELMD
Electromed
+2.25%-2.68%-35.85%-26.63%+15.22%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-0.86%-12.77%-29.04%-58.88%-80.85%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
+4.96%-14.44%-6.82%+0.98%+75.94%
Profound Medical stock logo
PROF
Profound Medical
+0.17%-13.35%-13.85%-9.95%+54.26%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Electromed, Inc. stock logo
ELMD
Electromed
$27.25
+2.3%		$38.25
$23.01
▼
$47.40
$227.97M0.4677,381 shs96,787 shs
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$0.72
-0.9%		$0.96
$0.67
▼
$4.71
$56.88M1.261.40 million shs833,121 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$62.81
+5.0%		$62.42
$23.47
▼
$77.00
$201.18M0.0661,145 shs63,035 shs
Profound Medical stock logo
PROF
Profound Medical
$5.97
+0.2%		$7.05
$3.90
▼
$8.95
$218.10M0.72105,980 shs362,006 shs
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Electromed, Inc. stock logo
ELMD
Electromed
+2.25%-2.68%-35.85%-26.63%+15.22%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-0.86%-12.77%-29.04%-58.88%-80.85%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
+4.96%-14.44%-6.82%+0.98%+75.94%
Profound Medical stock logo
PROF
Profound Medical
+0.17%-13.35%-13.85%-9.95%+54.26%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Electromed, Inc. stock logo
ELMD
Electromed
2.75
Moderate Buy$43.7560.55% Upside
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
2.50
Moderate Buy$4.33498.69% Upside
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
2.67
Moderate Buy$74.0017.82% Upside
Profound Medical stock logo
PROF
Profound Medical
2.67
Moderate Buy$11.5092.63% Upside

Current Analyst Ratings Breakdown

Latest NNOX, PROF, PDEX, and ELMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/11/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Ascendiant Capital Markets logo
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$70.00 ➝ $74.00
9/4/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C+) ➝ Buy (B-)
8/26/2026
Electromed, Inc. stock logo
ELMD
Electromed
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$50.00
8/26/2026
Electromed, Inc. stock logo
ELMD
Electromed
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$36.00 ➝ $47.00
8/24/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy (B-) ➝ Hold (C+)
8/17/2026
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$5.00
8/12/2026
Profound Medical stock logo
PROF
Profound Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
8/6/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C+) ➝ Buy (B-)
7/29/2026
Profound Medical stock logo
PROF
Profound Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/27/2026
Profound Medical stock logo
PROF
Profound Medical
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeOutperform ➝ Strong-Buy$11.00
7/17/2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy (B-) ➝ Hold (C+)
(Data available from 9/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Electromed, Inc. stock logo
ELMD
Electromed
$73.78M3.09$0.66 per share41.36$5.10 per share5.34
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
$15.63M3.64N/AN/A$2.01 per share0.36
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$77.55M2.59$4.10 per share15.33$14.92 per share4.21
Profound Medical stock logo
PROF
Profound Medical
$19.09M11.43N/AN/A$1.83 per share3.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Electromed, Inc. stock logo
ELMD
Electromed
$5.15M$1.3136.33N/AN/A11.34%15.71%13.37%N/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$75.02M-$2.14N/AN/AN/A-926.05%-116.93%-100.67%11/19/2026 (Estimated)
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$13.66M$4.1315.21N/AN/A17.62%25.13%16.02%10/29/2026 (Estimated)
Profound Medical stock logo
PROF
Profound Medical
-$42.57M-$0.98N/AN/AN/A-171.57%-63.03%-51.24%11/12/2026 (Estimated)

Latest NNOX, PROF, PDEX, and ELMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/9/2026Q2 2026
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
-$0.1620-$0.79-$0.6280-$0.79$5.38 million$4.16 million
9/3/2026Q4 2026
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$0.67$0.87+$0.20$0.87$19.20 million$20.40 million
8/6/2026Q2 2026
Profound Medical stock logo
PROF
Profound Medical
-$0.22-$0.26-$0.04$0.26$4.75 million$2.48 million
6/25/2026Q1 2026
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/A-$0.16N/A-$0.20N/A$4.31 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Electromed, Inc. stock logo
ELMD
Electromed
N/AN/AN/AN/AN/A
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
Profound Medical stock logo
PROF
Profound Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Electromed, Inc. stock logo
ELMD
Electromed
N/A
5.10
4.74
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
N/A
2.84
3.40
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.28
4.10
2.45
Profound Medical stock logo
PROF
Profound Medical
N/A
6.46
5.31

Institutional Ownership

CompanyInstitutional Ownership
Electromed, Inc. stock logo
ELMD
Electromed
40.82%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
21.49%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%
Profound Medical stock logo
PROF
Profound Medical
47.86%

Insider Ownership

CompanyInsider Ownership
Electromed, Inc. stock logo
ELMD
Electromed
10.50%
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
7.74%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
45.90%
Profound Medical stock logo
PROF
Profound Medical
1.52%
CompanyEmployeesShares OutstandingFree FloatOptionable
Electromed, Inc. stock logo
ELMD
Electromed
1608.37 million7.36 millionOptionable
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
19078.59 million72.51 millionOptionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
1403.20 million1.73 millionNot Optionable
Profound Medical stock logo
PROF
Profound Medical
15036.53 million35.98 millionOptionable

Recent News About These Companies

Profound Medical (NASDAQ:PROF) Downgraded to Sell Rating by Wall Street Zen
September 12 at 1:12 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31017642
Profound Medical (NASDAQ:PROF) Downgraded to "Sell" Rating by Wall Street Zen
September 12 at 1:11 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-profound-medical-nasdaq-prof-downgraded-to-sell-rating-by-wall-street-zen-2026-09-12/
Profound Medical Stock And 2 Canadian AI Healthcare Stocks To Watch
September 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/profound-medical-stock-2-canadian-021452828.html
Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference
September 3, 2026  |  financialpost.comF
Profound Medical to Participate in Lake Street's 10th Annual Best Ideas Growth Conference
September 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/03/3355888/33471/en/profound-medical-to-participate-in-lake-street-s-10th-annual-best-ideas-growth-conference.html
Profound Medical Appoints Richard Fabian President
September 2, 2026  |  marketscreener.comM
Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President
September 1, 2026  |  financialpost.comF
Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President
September 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/01/3354103/33471/en/profound-medical-further-strengthens-executive-leadership-team-with-appointment-of-richard-fabian-as-president.html
Profound Medical (NASDAQ:PROF) Trading Down 1.6% - Here's What Happened
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-profound-medical-nasdaq-prof-trading-down-16-heres-what-happened-2026-08-28/
Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’
August 17, 2026  |  financialpost.comF
Profound's Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days'
August 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/17/3346091/33471/en/profound-s-introduction-of-new-real-time-interventional-mri-software-paving-the-way-for-full-tulsa-days.html
Profound Medical CFO Dewan Steps Down; Sobczyk Named Interim CFO
August 15, 2026  |  marketwatch.comhttps://www.marketwatch.com/story/profound-medical-cfo-dewan-steps-down-sobczyk-named-interim-cfo-1cfcc8c5
Profound Medical names interim CFO
August 14, 2026  |  msn.comhttps://www.msn.com/en-us/money/companies/profound-medical-names-interim-cfo/ar-AA2a8sHO
Profound Medical Announces Management Change
August 14, 2026  |  financialpost.comF
Profound Medical Announces Management Change
August 14, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/profound-medical-announces-management-change-1036460936
Profound Medical Announces Management Change
August 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/14/3345631/33471/en/profound-medical-announces-management-change.html
Profound Medical (PROF) Q2 2026 Earnings Call Transcript
August 13, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/profound-medical-prof-q2-2026-234424215.html
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
August 13, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/profound-medical-launches-let-s-huddle-a-global-community-supporting-men-throughout-their-prostate-care-journey-1036455837
Profound Medical Launches ‘Let’s Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
August 13, 2026  |  financialpost.comF
Profound Medical Launches ‘Let's Huddle', a Global Community Supporting Men Throughout Their Prostate Care Journey
August 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344963/33471/en/profound-medical-launches-let-s-huddle-a-global-community-supporting-men-throughout-their-prostate-care-journey.html
Profound Medical Q2 Earnings Call Highlights
August 7, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/profound-medical-q2-earnings-call-090401948.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Red Tesla vehicle parked beside a building displaying the Tesla logo, with mountains in the background.
Can Tesla’s Flying Roadster Distract From Its Real Risks?
By Sam Quirke | August 26, 2026
Illuminated glass panel displaying the Okta logo in a dark server room and office setting.
Okta’s AI Tailwind Could Put This Forgotten Software Stock Back in Play
By Sam Quirke | August 19, 2026
Conceptual illustration of a stock price chart rising sharply in green before turning red at the peak, set against storm clouds.
3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
By Dan Schmidt | August 22, 2026
Rubrik logo displayed on a wall in a data center hallway lined with illuminated server racks.
Rubrik’s AI Security Bet Could Power the Next Leg Higher
By Thomas Hughes | August 30, 2026
Glass vials, flasks, test tubes, and a microscope in a laboratory setting with scientific analysis equipment.
Insiders Are Betting Big on These 3 Healthcare Stocks
By Thomas Hughes | August 31, 2026
Electromed stock logo

Electromed NYSE:ELMD

$27.25 +0.60 (+2.25%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$27.25 0.00 (0.00%)
As of 09/11/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Nano-X Imaging stock logo

Nano-X Imaging NASDAQ:NNOX

$0.72 -0.01 (-0.86%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$0.73 +0.01 (+0.72%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Pro-Dex stock logo

Pro-Dex NASDAQ:PDEX

$62.81 +2.97 (+4.96%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$62.70 -0.11 (-0.17%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Profound Medical stock logo

Profound Medical NASDAQ:PROF

$5.97 +0.01 (+0.17%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$5.79 -0.18 (-3.02%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas